ÂÜÀòÂÒÂ×

Nooshin Hashemi is an accomplished medical professional specializing in oncology, currently serving as the Executive Medical Director, Oncology Development, Global Lead at Astellas Pharma. Previously, Nooshin Hashemi held various pivotal roles at Amgen, including Early Clinical Development Lead and Medical Director in Hematology/Oncology. An academic background includes significant positions at the University of Cincinnati Cancer Institute, where Nooshin Hashemi progressed from Assistant Professor to Adjunct Associate Professor of Medicine, and experience at the Cleveland Clinic Foundation as an Assistant Professor of Medicine. Nooshin Hashemi's education includes extensive training at the Cleveland Clinic Foundation and Case Comprehensive Cancer Center between 2008 and 2011.